Overcoming Antimicrobial Resistance of the Skin

Stephen K. Tyring, MD, PhDUniversity of Texas Health Science CenterCenter for Clinical StudiesHouston, TXUSA Stephen Andrew MooreArlington Center for DermatologyArlington Research CenterArlington, TXUSA Angela Yen Moore, MDArlington Center for DermatologyArlington Research CenterArlington, TXUSA Omar Lupi, MD, MSc, PhDUniversidade Federal do Estado do Rio de Janeiro (UNIRIO)Policlinica Geral do Rio de Janeiro (PGRJ)Ibero Latin American College of Dermatology (CILAD) International League of Dermatological Societies (ILDS)Brazil

• Section I: Emerging Bacterial Resistance to Antibiotics.- Ch 1: Mechanisms of Bacterial Resistance.- Ch 2: Emerging Bacterial Infections.- Ch 3: Re-Emerging Bacterial Infections of the Skin.- Section II: Emerging Resistance to Antivirals.- Ch 4: Mechanisms of Nonretroviral Resistance.- Ch 5: Mechanisms of Retroviral Resistance.- Ch 6: Emerging Viral Infections.- Ch 7: Re-Emerging Viral Infections - Implications of Lack of Vaccination.- Section III: Emerging Resistance to Antifungals.- Ch 8: Mechanisms of Antifungal Resistance.- Ch 9: Emerging and Re-Emerging Fungal Infections.- Section IV: Emerging Resistance to Drugs for Protozoan and Helminth Infections.- Ch 10: Mechanisms of Anti-Protozoan/Helminth Drug Resistance.- Ch 11: Emerging and Re-Emerging Protozoan/Helminth Infections.- Section V: Innovative Therapies on the Forefront.- Ch 12: Phage Therapy.- Ch 13: The Role of Biofilms and the Microbiome.- Ch 14: New Classes of Broad-Spectrum Antibioticsand New Mechanisms of Delivery.- Ch 15: Phytocompounds.- Ch 16: Summary: Overcoming Antimicrobial Resistance of the Skin.